Exchange: OTC·Updated 09:30 AM EDT

AMBS Amarantus Bioscience Holdings Inc

$0.00
$0.00
(0.00%)
Today
Mkt Cap$630.00
Vol1.27M

About AMBS

Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.
50

Neutral Sentiment

How do you feel about AMBS?

Advertisement|Remove ads.